NeoStem (NBS) to Acquire California Stem Cell in Cash, Stock Deal – StreetInsider.com (subscription)
|
NeoStem (NBS) to Acquire California Stem Cell in Cash, Stock Deal
StreetInsider.com (subscription) Inc. (“CSC”), an Irvine, California based stem cell biotechnology company. As a result of this acquisition, NeoStem plans to initiate a pivotal Phase 3 trial of Melapuldencel-T, an autologous melanoma initiating (stem) cell immune based therapy … |
